相关实验视频
Updated: May 23, 2025

07:34
Use of Animal Model of Sepsis to Evaluate Novel Herbal Therapies
Published on: April 11, 2012
19.3K
重症性败血症患者的药使用和28天死亡率:使用MIMIC-IV (v3.1) 进行的回顾性队列研究
Yan Liang1, Feiyi Xu1,2, Hao Zhang3
1The First Affiliated Hospital Of Guilin Medical University, No. 15, Lequn Road, Xiufeng District, Guilin, Guangxi Province, China.
Journal of intensive care
|May 21, 2025
概括
在败血症患者中,酸盐改善了生存和肠道恢复,而乳糖与更糟糕的结果有关. 这凸显了在重症监护中需要个性化药选择,以改善患者的康复.
科学领域:
- 关键护理医学 关键护理医学
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
背景情况:
- 优化肠道管理对于重症败血症患者至关重要.
- 药的选择可能会影响患者的结果,包括死亡率和Clostridium difficile感染.
- 目前关于败血症的药疗效的证据有限.
研究的目的:
- 为了比较Senna,Docusate Sodium,Polyethylene Glycol和Lactulose对败血症患者结果的影响.
- 确定最佳的药策略,以改善严重性败血症患者的生存和康复.
- 分析药对28天死亡率,无ICU日,无呼吸器日,肠道恢复和C. difficile感染的影响.
主要方法:
- 来自MIMIC-IV数据库的7163名ICU败血症患者的分析 (v3.1).1).
- 评估结果,包括28天死亡率,无ICU日,无呼吸器日,肠道声音恢复和C. difficile发病率.
- 应用倾向性得分匹配和多变量调整对混因子的应用,并进行子组分析.
主要成果:
- 与Senna相比,Docusate Sodium与28天死亡率显著降低 (aHR:0.43) 以及改善肠道恢复有关.
- 乳糖使用与较高的死亡率 (aHR:1.82),较少的无ICU日和增加的C. difficile风险有关.
- 亚组分析证实了各种患者层面的这些趋势.
结论:
- 在重症毒症患者中,酸似乎是一种更安全,更有效的肠道管理选择.
- 乳糖与不良结果的关联可能受潜在的肝病严重程度的影响.
- 基于临床背景的个性化药选择在重症监护实践中至关重要.
相关概念视频
Endoscopic Procedures IV: Sigmoidoscopy and Laproscopy
38
Sigmoidoscopy and laparoscopy are distinct medical procedures that enable physicians to internally inspect different parts of the GI tract. Although they serve different purposes, each is essential for diagnosing and, in some cases, treating various medical conditions.
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
Sigmoidoscopy
Sigmoidoscopy is a diagnostic procedure that uses a flexible sigmoidoscope equipped with a light source and camera to examine the rectum and sigmoid colon. The procedure involves inserting the tube through the anus...
38
Drugs for Treatment of Constipation-Predominant IBS
124
Pharmacological therapies for IBS-C are designed to alleviate abdominal discomfort and enhance bowel function. In patients with IBS-C, fiber supplements may help soften stools and decrease straining, but may also lead to increased gas production and bloating. Osmotic laxatives like milk of magnesia are frequently used to soften stools and increase stool frequency in IBS-C patients. In addition, two drugs approved for use in severe IBS-C adult cases are linaclotide (Linzess) and lubiprostone...
124
Drugs for Treatment of Diarrhea-Predominant IBS
133
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
133

